19
Participants
Start Date
April 30, 2013
Primary Completion Date
June 30, 2014
Study Completion Date
June 30, 2014
Progesterone
Subjects will receive oral progesterone 400 mg (two x 200 mg capsules) once daily every evening for 7 days
Placebo
Subjects will receive oral placebo two capsules once daily every evening for 7 days
Ibutilide
Ibutilide 0.003 mg/kg administered to all subjects to moderately lengthen the QT interval
Indiana Clinical Research Center, Indianapolis
Purdue University, Indianapolis
American Heart Association
OTHER
Indiana University
OTHER